14-93939136-G-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001202429.2(ASB2):c.1589C>A(p.Ala530Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000181 in 1,546,862 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001202429.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ASB2 | NM_001202429.2 | c.1589C>A | p.Ala530Glu | missense_variant | 8/10 | ENST00000555019.6 | NP_001189358.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ASB2 | ENST00000555019.6 | c.1589C>A | p.Ala530Glu | missense_variant | 8/10 | 1 | NM_001202429.2 | ENSP00000451575 | P1 | |
ASB2 | ENST00000315988.8 | c.1445C>A | p.Ala482Glu | missense_variant | 6/8 | 1 | ENSP00000320675 | |||
ASB2 | ENST00000555507.5 | c.1283C>A | p.Ala428Glu | missense_variant | 6/7 | 5 | ENSP00000450940 | |||
ASB2 | ENST00000553883.1 | n.1360C>A | non_coding_transcript_exon_variant | 1/3 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152208Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000231 AC: 4AN: 172876Hom.: 0 AF XY: 0.0000316 AC XY: 3AN XY: 95058
GnomAD4 exome AF: 0.0000186 AC: 26AN: 1394654Hom.: 0 Cov.: 30 AF XY: 0.0000160 AC XY: 11AN XY: 685696
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152208Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74366
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 21, 2022 | The c.1589C>A (p.A530E) alteration is located in exon 8 (coding exon 7) of the ASB2 gene. This alteration results from a C to A substitution at nucleotide position 1589, causing the alanine (A) at amino acid position 530 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at